Editorial: Prognostic Gene Signatures in Skin Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Zaidi N, Jaffee E
. Immunotherapy transforms cancer treatment. J Clin Invest. 2018; 129(1):46-47.
PMC: 6307941.
DOI: 10.1172/JCI126046.
View
2.
Barrett T, Wilhite S, Ledoux P, Evangelista C, Kim I, Tomashevsky M
. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2012; 41(Database issue):D991-5.
PMC: 3531084.
DOI: 10.1093/nar/gks1193.
View
3.
Thornton J, Chhabra G, Singh C, Guzman-Perez G, Shirley C, Ahmad N
. Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter. Front Oncol. 2022; 12:880876.
PMC: 9066268.
DOI: 10.3389/fonc.2022.880876.
View
4.
Tomczak K, Czerwinska P, Wiznerowicz M
. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015; 19(1A):A68-77.
PMC: 4322527.
DOI: 10.5114/wo.2014.47136.
View
5.
Huang A, Zappasodi R
. A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance. Nat Immunol. 2022; 23(5):660-670.
PMC: 9106900.
DOI: 10.1038/s41590-022-01141-1.
View